A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature data

[1]  J. H. Lee,et al.  Accidental Intra-Arterial Infusion of Amiodarone in a Pediatric Patient With Atrial Ectopic Tachycardia. , 2016, Critical care medicine.

[2]  T. Paul,et al.  Adjunctive ivabradine in combination with amiodarone: A novel therapy for pediatric congenital junctional ectopic tachycardia. , 2016, Heart rhythm.

[3]  J. Marriott,et al.  Paediatric pharmacokinetics: key considerations. , 2015, British journal of clinical pharmacology.

[4]  B. Poindexter,et al.  Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents , 2014, Clinical pharmacology and therapeutics.

[5]  E. A. Greene,et al.  Management of Pediatric Tachyarrhythmias on Mechanical Support , 2014, Circulation. Arrhythmia and electrophysiology.

[6]  R. Berg,et al.  Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. , 2014, Resuscitation.

[7]  B. Meibohm,et al.  Pharmacokinetics of intravenous amiodarone in children , 2013, Archives of Disease in Childhood.

[8]  Nick Holford,et al.  A pharmacokinetic standard for babies and adults. , 2013, Journal of pharmaceutical sciences.

[9]  R. Hines.  Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children. , 2013, International journal of pharmaceutics.

[10]  Hironori Matsuhisa,et al.  Landiolol for junctional ectopic tachycardia refractory to amiodarone after pediatric cardiac surgery , 2013, General Thoracic and Cardiovascular Surgery.

[11]  Jeffrey J. Kim,et al.  Amiodarone Monitoring Practices in Pediatric Hospitals in the United States , 2013, Pediatric Cardiology.

[12]  H. Sasaki,et al.  Population Pharmacokinetic Investigation for Optimization of Amiodarone Therapy in Japanese Patients , 2011, Therapeutic drug monitoring.

[13]  J. Ramos,et al.  Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults , 2011, Pharmaceutics.

[14]  Vinay M Nadkarni,et al.  Part 14: Pediatric Advanced Life Support , 2010 .

[15]  Mark Terry,et al.  Part 13: pediatric basic life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.

[16]  Vinay M Nadkarni,et al.  Pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Pediatrics.

[17]  M. Silka,et al.  Amiodarone Versus Procainamide for the Acute Treatment of Recurrent Supraventricular Tachycardia in Pediatric Patients , 2010, Circulation. Arrhythmia and electrophysiology.

[18]  H. Sakaguchi,et al.  Combined amiodarone and low‐dose carvedilol treatment for severe heart failure in childhood , 2010, Pediatrics international : official journal of the Japan Pediatric Society.

[19]  S. Fishberger,et al.  Amiodarone for Pediatric Resuscitation: A Word of Caution , 2009, Pediatric Cardiology.

[20]  N. Haas,et al.  Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. , 2008, The Journal of thoracic and cardiovascular surgery.

[21]  D. Brocks,et al.  The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole. , 2008, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[22]  N. Holford,et al.  Mechanism-based concepts of size and maturity in pharmacokinetics. , 2008, Annual review of pharmacology and toxicology.

[23]  A. Dipchand,et al.  Amiodarone–sirolimus/tacrolimus interaction in a pediatric heart transplant patient , 2006, Pediatric transplantation.

[24]  R. Berg,et al.  Outcomes of in-hospital ventricular fibrillation in children. , 2006, The New England journal of medicine.

[25]  J. Ornato,et al.  First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults. , 2006, JAMA.

[26]  J. Triedman,et al.  Intravenous Amiodarone for Incessant Tachyarrhythmias in Children: A Randomized, Double-Blind, Antiarrhythmic Drug Trial , 2005, Circulation.

[27]  P. Berden,et al.  Repetitive Paroxysms of Supraventricular Tachyarrhythmias Triggered During Pediatric Cardiac Interventions: Suppression After Short Infusion of Amiodarone , 2004, Pediatric Cardiology.

[28]  U. Bauersfeld,et al.  Efficacy and safety of intravenous amiodarone for incessant tachycardias in infants , 2003, European Journal of Pediatrics.

[29]  Ewald R. Weibel,et al.  Physiology: The pitfalls of power laws , 2002, Nature.

[30]  G. V. Van Hare,et al.  Survey of current practices in use of amiodarone and implantable cardioverter defibrillators in pediatric patients with end-stage heart failure. , 2001, The American journal of cardiology.

[31]  T. Bouillon,et al.  Population pharmacokinetics of long‐term oral amiodarone therapy , 2000, Clinical pharmacology and therapeutics.

[32]  R. Marinchak,et al.  Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs. , 1997, The American journal of cardiology.

[33]  S. Troy,et al.  Population Pharmacokinetics of Intravenous Amiodarone and Comparison with Two‐Stage Pharmacokinetic Analysis , 1997, Journal of clinical pharmacology.

[34]  J. Korth-Bradley,et al.  Population Pharmacokinetics of Intravenous Amiodarone in Patients with Refractory Ventricular Tachycardia/Fibrillation , 1996, Journal of clinical pharmacology.

[35]  M. Chow,et al.  Intravenous Amiodarone: Pharmacology, Pharmacokinetics, and Clinical use , 1996, The Annals of pharmacotherapy.

[36]  J. Triedman,et al.  Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. , 1996, Journal of the American College of Cardiology.

[37]  J. Janousek,et al.  New antiarrhythmic drugs in pediatric use: Propafenone , 1994, Pediatric Cardiology.

[38]  T. Paul,et al.  New Antiarrhythmic drugs in pediatric use: Amiodarone , 1994, Pediatric Cardiology.

[39]  M. D. Freedman,et al.  Pharmacology and Pharmacokinetics of Amiodarone , 1991, Journal of clinical pharmacology.

[40]  P. Wyss,et al.  Single-dose kinetics of tissue distribution, excretion and metabolism of amiodarone in rats. , 1990, The Journal of pharmacology and experimental therapeutics.

[41]  D J Greenblatt,et al.  Pharmacokinetics and pharmacodynamics. , 1990, Hospital practice.

[42]  M. E. Veronese,et al.  Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method. , 1988, British journal of clinical pharmacology.

[43]  M. Dick,et al.  Amiodarone in Pediatric Patients , 1986 .

[44]  R. Kannan,et al.  Tissue uptake and metabolism of amiodarone after chronic administration in rabbits. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[45]  John E. Dennis,et al.  Numerical methods for unconstrained optimization and nonlinear equations , 1983, Prentice Hall series in computational mathematics.

[46]  A. Maggioni,et al.  Pharmacokinetics of Amiodarone in Man , 1982, Journal of cardiovascular pharmacology.

[47]  E. Riva,et al.  Pharmacokinetics of Amiodarone in Rats , 1982, Journal of cardiovascular pharmacology.

[48]  S. Balaji,et al.  Cardiovascular collapse during amiodarone infusion in a hemodynamically compromised child with refractory supraventricular tachycardia , 2015, Annals of pediatric cardiology.

[49]  J. Stockman,et al.  First Documented Rhythm and Clinical Outcome From In-Hospital Cardiac Arrest Among Children and Adults , 2007 .

[50]  R. Upton.  Calculating the hybrid (macro) rate constants of a three-compartment mamillary pharmacokinetic model from known micro-rate constants. , 2004, Journal of pharmacological and toxicological methods.

[51]  S. Etheridge,et al.  Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. , 2001, American heart journal.

[52]  W. Mckenna,et al.  Amiodarone pharmacokinetics. , 1986, British journal of clinical practice. Supplement.

[53]  J. V. van Rossum,et al.  Pharmacokinetics and body distribution of amiodarone in man. , 1984, Arzneimittel-Forschung.